Genomic Health Company Profile (NASDAQ:GHDX)

Analyst Ratings

Consensus Ratings for Genomic Health (NASDAQ:GHDX) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $33.50 (18.79% upside)

Analysts' Ratings History for Genomic Health (NASDAQ:GHDX)
Show:
DateFirmActionRatingPrice TargetActions
6/21/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2016Canaccord GenuityUpgradeHold -> Buy$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Jefferies GroupReiterated RatingHold$24.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Piper Jaffray Cos.Reiterated RatingIn-Line$32.00 -> $31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Raymond James Financial Inc.UpgradeMarket Perform -> Outperform$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015JMP SecuritiesBoost Price TargetOutperform$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Credit Suisse Group AGReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Wells Fargo & Co.Initiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Bank of America Corp.Reiterated RatingBuy$28.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Genomic Health (NASDAQ:GHDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/4/2016Q1($0.24)($0.19)$78.12 million$80.89 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2016Q415($0.09)($0.10)$74.03 million$74.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315($0.18)($0.36)$73.35 million$73.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215($0.27)($0.29)$71.65 million$70.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q115($0.26)($0.30)$68.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414($0.22)($0.20)$72.20 million$69.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314($0.22)($0.20)$71.00 million$69.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214($0.26)($0.15)$69.04 million$70.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114($0.18)($0.24)$68.47 million$67.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2014Q413($0.03)($0.30)$69.20 million$68.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313($0.04)$0.02$64.98 million$65.99 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2013Q2 2013($0.08)($0.10)$63.91 million$63.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.02)($0.03)$62.90 million$63.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q4 2012$0.03$0.06$58.90 million$60.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312$0.05$0.11$59.87 million$58.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.02)$0.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012($0.02)$0.02ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2012$0.09$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2011$0.03$0.10ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/3/2011$0.02$0.08ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011$0.02($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/8/2011$0.06$0.06ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Genomic Health (NASDAQ:GHDX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165($0.25)($0.07)($0.17)
Q2 20167($0.20)($0.01)($0.11)
Q3 20165($0.15)$0.01($0.04)
Q4 20167($0.02)$0.04$0.01
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Genomic Health (NASDAQ:GHDX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Genomic Health (NASDAQ:GHDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
7/19/2016Steven ShakInsiderSell5,000$27.42$137,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/6/2016G Bradley ColeCOOSell5,000$26.64$133,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/21/2016Steven ShakInsiderSell5,000$25.77$128,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016G Bradley ColeCOOSell5,000$26.62$133,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2016James J VaughnInsiderSell1,997$28.00$55,916.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2016G Bradley ColeCOOSell5,000$27.60$138,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2016Phillip G FebboInsiderSell6,324$27.20$172,012.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2016Steven ShakInsiderSell10,000$25.43$254,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2016Randall S. LivingstonDirectorSell1,250$32.14$40,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016G Bradley ColeCOOSell4,000$31.69$126,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2016James J. VaughninsiderSell2,000$33.63$67,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2015G Bradley ColeCOOSell4,000$29.26$117,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015James J. VaughninsiderSell2,000$29.33$58,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015G Bradley ColeCOOSell4,000$26.03$104,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2015G Bradley ColeCOOSell9,664$25.35$244,982.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2015G Bradley ColeCOOSell4,000$27.53$110,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015G Bradley ColeCOOSell4,000$26.24$104,960.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Kimberly J PopovitsCEOSell3,000$31.28$93,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2015G Bradley ColeCOOSell4,000$30.44$121,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Randall S LivingstonDirectorSell1,000$31.93$31,930.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Kimberly J PopovitsCEOSell3,000$33.46$100,380.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014G Bradley ColeCOOSell4,336$32.52$141,006.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Kimberly J PopovitsCEOSell4,300$34.82$149,726.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/13/2014Kimberly J PopovitsCEOSell3,000$30.78$92,340.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/8/2014G Bradley ColeCOOSell4,000$28.77$115,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2014Kimberly J PopovitsCEOSell3,000$29.82$89,460.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/8/2014G Bradley ColeCOOSell4,700$30.09$141,423.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014Steven ShakEVPSell13,348$27.36$365,201.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014Steven ShakEVPSell7,000$27.25$190,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014Kimberly J PopovitsCEOSell3,000$26.59$79,770.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2014G Bradley ColeCOOSell2,300$27.05$62,215.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Steven ShakEVPSell7,000$27.00$189,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Steven ShakEVPSell7,000$26.25$183,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2014G Bradley ColeCOOSell3,000$27.00$81,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Steven ShakEVPSell7,000$28.36$198,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Kathy HibbsSVPSell1,312$27.88$36,578.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2014Steven ShakEVPSell7,000$31.51$220,570.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Kimberly PopovitsCEOSell2,500$30.00$75,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2013Steven ShakCMOSell14,000$29.57$413,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/12/2013Kimberly PopovitsCEOSell2,500$30.68$76,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2013Dean SchornoCFOSell3,000$33.25$99,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Steven ShakCMOSell5,000$29.67$148,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2013Kimberly PopovitsCEOSell2,500$30.00$75,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2013G Bradley ColeCOOSell2,500$29.95$74,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Steven ShakCMOSell5,000$33.73$168,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Kimberly PopovitsCEOSell2,500$34.31$85,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013G Bradley ColeCOOSell2,500$32.53$81,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2013Dean L SchornoCFOSell4,000$32.90$131,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Randall LivingstonDirectorSell1,000$31.49$31,490.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Steven ShakCMOSell5,000$32.98$164,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2013Kimberly PopovitsCEOSell2,500$33.03$82,575.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2013Dean SchornoCFOSell4,000$33.15$132,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013G Bradley ColeCOOSell2,500$33.66$84,150.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/23/2013Steven ShakCMOSell5,000$35.33$176,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/12/2013Kimberly J PopovitsCEOSell5,000$34.61$173,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2013Dean L SchornoCFOSell4,000$33.81$135,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/8/2013G Bradley ColeCOOSell2,500$33.33$83,325.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/18/2013Steven ShakCMOSell5,000$33.52$167,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/12/2013Kimberly J PopovitsCEOSell5,000$35.68$178,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Dean L SchornoCFOSell4,000$35.88$143,520.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013Felix BakerDirectorBuy381,432$36.16$13,792,581.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2013G Bradley ColeCOOSell2,500$36.47$91,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Felix BakerDirectorBuy179,583$36.71$6,592,491.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2013Felix BakerDirectorBuy121,266$36.89$4,473,502.74View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2013Felix BakerDirectorBuy79,417$36.93$2,932,869.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2013Kathy L HibbsSVPSell1,000$37.48$37,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Steven ShakCMOSell5,000$37.19$185,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/16/2013Felix BakerDirectorBuy71,439$36.45$2,603,951.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Randall S LivingstonDirectorSell1,337$35.83$47,904.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Felix BakerDirectorBuy240,426$34.34$8,256,228.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Kathy L HibbsSVPSell1,250$34.42$43,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Kimberly J PopovitsCEOSell5,000$34.70$173,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013Dean L SchornoCFOSell4,000$36.02$144,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013G Bradley ColeCOOSell2,500$35.99$89,975.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/21/2013Felix BakerDirectorBuy49,085$27.78$1,363,581.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2013Woodrow A Myers JrDirectorSell41,250$28.40$1,171,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2013Felix BakerDirectorBuy116,360$28.15$3,275,534.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Randall S LivingstonDirectorSell2,000$27.84$55,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2012Felix BakerDirectorBuy229,300$26.83$6,152,119.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Felix BakerDirectorBuy103,167$27.32$2,818,522.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2012Felix BakerDirectorBuy823,772$27.81$22,909,099.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Dean L SchornoCFOSell3,000$28.00$84,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/8/2012G Bradley ColeCOOSell2,500$28.62$71,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Genomic Health (NASDAQ:GHDX)
DateHeadline
07/22/16 07:08 AMCould Genomic Health, Inc. Decline After Today's Huge Increase? - Press Telegraph
07/20/16 07:03 AMEquity Roundup: Stock Performance Focus on Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph
07/20/16 07:03 AMGenomic Health, Inc. (NASDAQ:GHDX) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/20/16 07:03 AMHow Analysts Rated Genomic Health, Inc. (NASDAQ:GHDX) Last Week? - Consumer Eagle
07/17/16 03:49 PMStrong Sell Calls For Genomic Health, Inc. (NASDAQ:GHDX) At 1 - Investor Newswire
07/15/16 07:08 AMNew Broker Ratings For Genomic Health, Inc. (NASDAQ:GHDX) - FTSE News
07/15/16 07:08 AMGenomic Health Incorporated (NASDAQ:GHDX) Shorts Decreased by 4% After Short Covering - Consumer Eagle
07/15/16 07:08 AMCrowd Rating and Earnings Recap for Genomic Health, Inc. (NASDAQ:GHDX) - Telanagana Press
07/15/16 07:08 AMOption Market: Genomic Health Inc Risk Hits An Inflection Point - CML News
07/13/16 07:05 AMTrading Performance and Target Watch for Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph
07/13/16 07:05 AMGenomic Health, Inc. (NASDAQ:GHDX) Current Analyst Ratings - Fiscal Standard
07/11/16 04:16 PMStock on the Rise for the Quarter: Genomic Health Inc. (NASDAQ:GHDX) - Engelwood Daily
07/11/16 04:16 PMCompany Stock Focus for Genomic Health, Inc. (NASDAQ:GHDX): Which Way Will Shares Head? - Press Telegraph
07/11/16 04:16 PMStock Performance Rundown on: Genomic Health Inc. (NASDAQ:GHDX) - Press Telegraph
07/11/16 04:16 PMGenomic Health to Offer Epic Science's AR-V7 test, Shares Up - Yahoo Finance
07/11/16 08:58 AMGenomic Health to Offer Epic Science's AR-V7 test, Shares Up
07/10/16 03:54 PMIs $39.5 Within Reach For Genomic Health, Inc. (NASDAQ:GHDX)? - Investor Newswire
07/10/16 03:54 PMGenomic Health Incorporated (NASDAQ:GHDX) Shorts Decreased by 4% After Short Covering - Engelwood Daily
07/08/16 04:11 PMEarnings Surprise in Focus: Genomic Health, Inc. (NASDAQ:GHDX) - Investor Newswire
07/08/16 07:01 AMGenomic Health and Epic Sciences Announce Strategic Collaboration to Deliver Novel AR-V7 Liquid Biopsy Test to ... - Yahoo Finance
07/08/16 07:01 AMGenomic Health Inc. Stock Momentum Hits Strength - CML News
07/07/16 07:36 AMGenomic Health inks deal with Epic Sciences to commercialize liquid biopsy test for prostate cancer -
07/07/16 07:02 AMStock Tracking Down This Month; Investor Alert on Genomic Health Inc. (NASDAQ:GHDX) - Engelwood Daily
07/07/16 07:02 AMGenomic Health, Inc. (NASDAQ:GHDX) Stock Update: Check on Ratings and Target Price - Telanagana Press
07/07/16 07:02 AMStock Rating Watch and Earnings Insight for Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph
07/07/16 07:02 AMBroker Outlook For Genomic Health, Inc. (NASDAQ:GHDX) - Fiscal Standard
07/06/16 11:11 PM[$$] Test Aids Prostate Cancer Treatment -
07/05/16 11:10 AMGenomic Health, Inc. – Value Analysis (NASDAQ:GHDX) : July 5, 2016 -
07/04/16 03:53 PMShare Performance Recap for: Genomic Health Inc. (NASDAQ:GHDX) - Press Telegraph
07/04/16 07:17 AMGenomic Health, Inc. breached its 50 day moving average in a Bullish Manner : GHDX-US : July 4, 2016 -
07/03/16 08:42 AMGenomic Health, Inc. (NASDAQ:GHDX) Expected to Reach Highs Of $39.5 - Investor Newswire
06/30/16 04:30 PMGenomic Health Incorporated (NASDAQ:GHDX) Shorts Decreased by 4% After Short Covering - Press Telegraph
06/30/16 07:03 AMGenomic Health, Inc. (NASDAQ:GHDX) Company Rating and Target Watch - Telanagana Press
06/29/16 04:16 AMShare Update and Earnings Review for Genomic Health, Inc. (NASDAQ:GHDX) - Press Telegraph
06/28/16 09:02 AMGenomic Health, Inc. (NASDAQ:GHDX) Earnings Glance and Target Price Review - Engelwood Daily
06/27/16 08:39 AMNext Weeks Broker Price Targets For Genomic Health, Inc. (NASDAQ:GHDX) - Fiscal Standard
06/26/16 03:43 PMWhy America's Advantage Is Innovation (CHKP, GHDX)
06/25/16 03:58 PMStrong Sell Calls Recommendations For Genomic Health, Inc. (NASDAQ:GHDX) At 1 - Investor Newswire
06/24/16 07:50 AMGenomic Health: Can the Liquid Biopsy Test Boost Margins? -
06/23/16 03:08 PMGENOMIC HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers -
06/20/16 10:28 AMThis Weeks Broker Views For Genomic Health, Inc. (NASDAQ:GHDX) - Fiscal Standard
06/19/16 08:30 AMStrong Buy Calls Count For Genomic Health, Inc. (NASDAQ:GHDX) At 5 - Investor Newswire
06/17/16 07:13 AMGenomic Health Brings Liquid Biopsy Test for Stage IV Cancer -
06/15/16 04:21 PMGENOMIC HEALTH INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/14/16 07:00 AMGenomic Health Launches Oncotype SEQ™ Liquid Biopsy Mutation Panel - [PR Newswire] - REDWOOD CITY, Calif., June 14, 2016 /PRNewswire/ -- Genomic Health, Inc. (GHDX) today announced the commercial launch of Oncotype SEQ™ Liquid Select, the first of several non-invasive liquid biopsy tests that the company plans to deliver through its Oncotype IQ™ Genomic Intelligence Platform. Oncotype SEQ is a blood-based test that uses next-generation sequencing to identify and assess actionable genomic alterations in a panel of 17 select genes to inform the treatment of stage IV solid tumors, including lung, breast, colon, melanoma, ovarian, and gastrointestinal stromal tumors. The test is designed to provide clinically actionable information focused on genomic markers that have either been included in National Comprehensive Cancer Network (NCCN®) guidelines or associated with sensitivity or resistance to relevant FDA-approved therapies.
06/10/16 04:20 PMBrokers Issue Average Price Target Of 31.82 On Genomic Health, Inc. (NASDAQ:GHDX) - Fiscal Standard
06/10/16 04:44 AMGenomic Health, Inc. (NASDAQ:GHDX) Earns Rating Score Of 2.27 - RealistInvestor.com
06/09/16 05:13 AMGenomic Health (GHDX) Announces Publication of Results from NCI Surveillance, Epidemiology, and End Results ... - StreetInsider.com
06/08/16 03:05 PMNature Partner Journals Publish Five-year Outcomes Results from SEER Registry Demonstrating Oncotype DX® Accurately Identifies Early-stage Breast Cancer Patients with Excellent Survival - [PR Newswire] - REDWOOD CITY, Calif., June 8, 2016 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from the National Cancer Institute's (NCI) Surveillance, Epidemiology, ...
06/07/16 09:55 PMGenomic Health, Inc. (NASDAQ:GHDX) Low Price Is Set At $25 - RealistInvestor.com

Social

About Genomic Health

Genomic Health logoGenomic Health, Inc. is a healthcare company, which provides genomic-based diagnostic tests for the treatment of early stage cancer. The Company offers its Oncotype DX tests as a clinical laboratory service, where it analyzes the expression levels of genes in tumor tissue samples and provides physicians with a quantitative gene expression profile expressed as a single quantitative score, which it calls a Recurrence Score for invasive breast cancer and colon cancer, a DCIS Score for ductal carcinoma in situ (DCIS) and a Genomic Prostate Score for prostate cancer. Its Oncotype DX tests utilizes quantitative genomic analysis known as reverse transcription polymerase chain reaction, in standard tumor pathology specimens to provide tumor-specific information, or the oncotype of a tumor. It offers its services and products, including Oncotype DX Breast Cancer Test, Oncotype DX Colon Cancer Test and Oncotype DX Prostate Cancer Test through its Oncotype IQ Genomic Intelligence Platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: GHDX
  • CUSIP: 37244C10
Key Metrics:
  • Previous Close: $28.20
  • 50 Day Moving Average: $26.75
  • 200 Day Moving Average: $27.01
  • P/E Ratio: N/A
  • P/E Growth: -11.39
  • Market Cap: $931.02M
  • Beta: 0.48
  • Current Year EPS Consensus Estimate: $-0.45 EPS
  • Next Year EPS Consensus Estimate: $0.12 EPS
Additional Links:
Genomic Health (NASDAQ:GHDX) Chart for Sunday, July, 24, 2016